Circulation, Vol 68, 1247-1253, Copyright © 1983 by American Heart Association
JD Horowitz, EM Antman, BH Lorell, WH Barry and TW Smith
The biochemical basis of the mechanism of vasodilatation by nitroglycerin
(NTG) has not been previously investigated in man. However, evidence from
in vitro studies suggests that NTG induces activation of guanylate cyclase
via a series of enzymatic reactions that are modulated by the availability
of sulfhydryl groups. Cysteine appears to be particularly effective in
potentiating guanylate cyclase activation by NTG. To determine whether
hemodynamic responsiveness to NTG in man might be modulated by sulfhydryl
availability, concentration- response curves for effects of intravenously
infused NTG on mean arterial pressure (MAP) and mean pulmonary capillary
wedge pressure (PCW) were obtained in 10 patients undergoing cardiac
catheterization for investigation of chest pain. NTG infusion was repeated
10 min after the intravenous infusion of 100 mg/kg of the cysteine source
N- acetylcysteine (NAC). NAC induced no significant hemodynamic effect, but
after NAC infusion there was a significant reduction both in the NTG
infusion rate associated with a 10% fall from control values in MAP (25.8
+/- 8.3 to 9.3 +/- 2.7 micrograms/min; p less than .01) and in the infusion
rate inducing a 30% reduction in PCW (13.6 +/- 4.6 to 4.2 +/- 1.6
micrograms/min; p less than .02). In a control group of five patients who
received no NAC, there was no significant change in responsiveness to NTG
between infusions. It is concluded that NAC potentiates the vasodilator
effects of NTG in man. This suggests that sulfhydryl availability and/or
redox state may be determinants of in vivo responsiveness to NTG.
ARTICLES
Potentiation of the cardiovascular effects of nitroglycerin by N- acetylcysteine
This article has been cited by other articles:
![]() |
J. D. Horowitz Amelioration of nitrate tolerance: matching strategies with mechanisms J. Am. Coll. Cardiol., June 4, 2003; 41(11): 2001 - 2003. [Full Text] [PDF] |
||||
![]() |
J. Loscalzo Folate and Nitrate-Induced Endothelial Dysfunction: A Simple Treatment for a Complex Pathobiology Circulation, September 4, 2001; 104(10): 1086 - 1088. [Full Text] [PDF] |
||||
![]() |
N. P. Andrews, A. Prasad, and A. A. Quyyumi N-acetylcysteine improves coronary and peripheral vascular function J. Am. Coll. Cardiol., January 1, 2001; 37(1): 117 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. O'Byrne, C. Shirodaria, T. Millar, C. Stevens, D. Blake, and N. Benjamin Inhibition of Platelet Aggregation with Glyceryl Trinitrate and Xanthine Oxidoreductase J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 326 - 330. [Abstract] [Full Text] |
||||
![]() |
A. Prasad, N. P. Andrews, F. A. Padder, M. Husain, and A. A. Quyyumi Glutathione reverses endothelial dysfunction and improves nitric oxide bioavailability J. Am. Coll. Cardiol., August 1, 1999; 34(2): 507 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-M. Sun, S. Doran, K. L. Jones, E. Ooi, G. Boeckxstaens, G. S. Hebbard, T. Lingenfelser, J. E. Morley, J. Dent, and M. Horowitz Effects of nitroglycerin on liquid gastric emptying and antropyloroduodenal motility Am J Physiol Gastrointest Liver Physiol, November 1, 1998; 275(5): G1173 - G1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Kearney, J. F. Brien, G. S. Marks, H. Lei, and K. Nakatsu Thiol Agents Separate Nitric Oxide Formation from Vasodilation Induced by Glyceryl Trinitrate Drug Metab. Dispos., June 1, 1998; 26(6): 547 - 551. [Abstract] [Full Text] |
||||
![]() |
J. D. Parker and J. O. Parker Nitrate Therapy for Stable Angina Pectoris N. Engl. J. Med., February 19, 1998; 338(8): 520 - 531. [Full Text] [PDF] |
||||
![]() |
M. A. Arstall, J. Yang, I. Stafford, W. H. Betts, and J. D. Horowitz N-Acetylcysteine in Combination With Nitroglycerin and Streptokinase for the Treatment of Evolving Acute Myocardial Infarction : Safety and Biochemical Effects Circulation, November 15, 1995; 92(10): 2855 - 2862. [Abstract] [Full Text] |
||||
![]() |
U. Elkayam Tolerance to Organic Nitrates: Evidence, Mechanisms, Clinical Relevance, and Strategies for Prevention Ann Intern Med, April 15, 1991; 114(8): 667 - 677. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1983 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |